Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists
US9593106B2 · kind B2 · utility
20Cited by
3References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 7, 2014 |
| Grant date | Mar 14, 2017 |
| Priority date | — |
| Expiry date | Feb 7, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides muscarinic M4 receptor agonists of formula (I) and pharmaceutically acceptable salts thereof, wherein m, n, p, q, R, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases such as schizophrenia, Alzheimer's disease and various cognitive disorders as well as in the treatment or alleviation of pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.